Ina Nemet

4.5k total citations · 2 hit papers
59 papers, 2.5k citations indexed

About

Ina Nemet is a scholar working on Molecular Biology, Physiology and Clinical Biochemistry. According to data from OpenAlex, Ina Nemet has authored 59 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 23 papers in Physiology and 22 papers in Clinical Biochemistry. Recurrent topics in Ina Nemet's work include Advanced Glycation End Products research (20 papers), Gut microbiota and health (15 papers) and Diet and metabolism studies (13 papers). Ina Nemet is often cited by papers focused on Advanced Glycation End Products research (20 papers), Gut microbiota and health (15 papers) and Diet and metabolism studies (13 papers). Ina Nemet collaborates with scholars based in United States, Croatia and South Korea. Ina Nemet's co-authors include Lidija Varga‐Defterdarovič, Vincent M. Monnier, Stanley L. Hazen, Zdenka Turk, Yoshikazu Imanishi, W.H. Wilson Tang, Philip Ropelewski, Michael A. Fischbach, Lin Li and Joseph A. DiDonato and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Ina Nemet

55 papers receiving 2.4k citations

Hit Papers

A Cardiovascular Disease-Linked Gut Microbial Metabolite ... 2020 2026 2022 2024 2020 2023 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ina Nemet United States 28 1.3k 689 557 364 243 59 2.5k
Diego Ingrosso Italy 33 1.3k 1.0× 459 0.7× 387 0.7× 168 0.5× 219 0.9× 106 3.6k
Arduino Arduini Italy 32 1.4k 1.1× 978 1.4× 775 1.4× 308 0.8× 170 0.7× 115 3.4k
Kerry-Ann da Costa United States 22 996 0.8× 556 0.8× 667 1.2× 280 0.8× 377 1.6× 30 3.2k
Stanislovas S. Jankauskas United States 29 1.7k 1.3× 485 0.7× 200 0.4× 367 1.0× 332 1.4× 89 3.7k
Marina Makrecka‐Kuka Latvia 27 1.2k 0.9× 644 0.9× 433 0.8× 184 0.5× 169 0.7× 68 2.2k
Carina Prip‐Buus France 34 2.1k 1.7× 776 1.1× 640 1.1× 325 0.9× 520 2.1× 64 3.4k
María M. Adeva‐Andany Spain 17 896 0.7× 580 0.8× 204 0.4× 403 1.1× 359 1.5× 32 2.4k
Isabel Tavares de Almeida Portugal 32 1.9k 1.5× 549 0.8× 1.3k 2.2× 179 0.5× 339 1.4× 112 3.8k
Clementina Mesaros United States 30 1.6k 1.3× 516 0.7× 180 0.3× 401 1.1× 195 0.8× 129 3.4k
Richard Hébert Canada 31 1.5k 1.1× 751 1.1× 276 0.5× 505 1.4× 140 0.6× 104 3.5k

Countries citing papers authored by Ina Nemet

Since Specialization
Citations

This map shows the geographic impact of Ina Nemet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ina Nemet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ina Nemet more than expected).

Fields of papers citing papers by Ina Nemet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ina Nemet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ina Nemet. The network helps show where Ina Nemet may publish in the future.

Co-authorship network of co-authors of Ina Nemet

This figure shows the co-authorship network connecting the top 25 collaborators of Ina Nemet. A scholar is included among the top collaborators of Ina Nemet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ina Nemet. Ina Nemet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glowacki, Robert W. P., et al.. (2025). Identification of strain-specific cues that regulate biofilm formation in Bacteroides thetaiotaomicron. Microbiology Spectrum. 13(10). e0341924–e0341924.
2.
Witkowski, Marco, Ina Nemet, Xinmin S. Li, et al.. (2024). Xylitol is prothrombotic and associated with cardiovascular risk. European Heart Journal. 45(27). 2439–2452. 26 indexed citations
3.
Tang, W.H. Wilson, Xinmin S. Li, Marcia C. de Oliveira Otto, et al.. (2024). The Gut Microbial Metabolite Trimethylamine N-oxide, Incident CKD, and Kidney Function Decline. Journal of the American Society of Nephrology. 35(6). 749–760. 21 indexed citations
4.
Tang, W.H. Wilson, Rozenn N. Lemaître, Paul N. Jensen, et al.. (2024). Trimethylamine N -Oxide and Related Gut Microbe-Derived Metabolites and Incident Heart Failure Development in Community-Based Populations. Circulation Heart Failure. 17(8). e011569–e011569. 13 indexed citations
5.
Witkowski, Marco, Jennifer Wilcox, Valesha M. Province, et al.. (2024). Ingestion of the Non-Nutritive Sweetener Erythritol, but Not Glucose, Enhances Platelet Reactivity and Thrombosis Potential in Healthy Volunteers—Brief Report. Arteriosclerosis Thrombosis and Vascular Biology. 44(9). 2136–2141. 10 indexed citations
6.
Lemaître, Rozenn N., Paul N. Jensen, Zeneng Wang, et al.. (2023). Plasma Trimethylamine‐ N ‐Oxide and Incident Ischemic Stroke: The Cardiovascular Health Study and the Multi‐Ethnic Study of Atherosclerosis. Journal of the American Heart Association. 12(16). e8711–e8711. 11 indexed citations
7.
Nemet, Ina, Masanori Funabashi, Xinmin S. Li, et al.. (2023). Microbe-derived uremic solutes enhance thrombosis potential in the host. mBio. 14(6). e0133123–e0133123. 8 indexed citations
8.
Witkowski, Marco, Ina Nemet, Hassan S. Alamri, et al.. (2023). The artificial sweetener erythritol and cardiovascular event risk. Nature Medicine. 29(3). 710–718. 115 indexed citations breakdown →
9.
Witkowski, Marco, Ina Nemet, Hassan S. Alamri, et al.. (2023). The artificial sweetener erythritol and cardiovascular event risk. Yearbook of pediatric endocrinology. 1 indexed citations
10.
Tang, W.H. Wilson, Ina Nemet, Xinmin S. Li, et al.. (2023). Prognostic Value of Gut Microbe-Generated Metabolite Phenylacetylglutamine in Patients with Heart Failure. European Journal of Heart Failure. 26(2). 233–241. 18 indexed citations
11.
Li, Xinmin S., Zeneng Wang, Marcia C. de Oliveira Otto, et al.. (2023). Trimethylamine N-oxide is associated with long-term mortality risk: the multi-ethnic study of atherosclerosis. European Heart Journal. 44(18). 1608–1618. 39 indexed citations
12.
Zhu, Yijun, Mohammed Dwidar, Ina Nemet, et al.. (2022). Two distinct gut microbial pathways contribute to meta-organismal production of phenylacetylglutamine with links to cardiovascular disease. Cell Host & Microbe. 31(1). 18–32.e9. 76 indexed citations
13.
Lee, Yujin, Ina Nemet, Zeneng Wang, et al.. (2021). Longitudinal Plasma Measures of Trimethylamine N‐Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community‐Based Older Adults. Journal of the American Heart Association. 10(17). e020646–e020646. 71 indexed citations
14.
Pathak, Preeti, Robert N. Helsley, Amanda L. Brown, et al.. (2020). Small molecule inhibition of gut microbial choline trimethylamine lyase activity alters host cholesterol and bile acid metabolism. American Journal of Physiology-Heart and Circulatory Physiology. 318(6). H1474–H1486. 65 indexed citations
15.
Nimer, Nisreen, Ibrahim Choucair, Zeneng Wang, et al.. (2020). Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression. Metabolism. 116. 154457–154457. 108 indexed citations
16.
Nemet, Ina, et al.. (2014). Submembrane Assembly and Renewal of Rod Photoreceptor cGMP-Gated Channel: Insight into the Actin-Dependent Process of Outer Segment Morphogenesis. Journal of Neuroscience. 34(24). 8164–8174. 28 indexed citations
17.
Monnier, Vincent M., Wanjie Sun, David R. Sell, et al.. (2013). Glucosepane: a poorly understood advanced glycation end product of growing importance for diabetes and its complications. Clinical Chemistry and Laboratory Medicine (CCLM). 52(1). 21–32. 57 indexed citations
18.
Ropelewski, Philip, et al.. (2013). Signals Governing the Trafficking and Mistrafficking of a Ciliary GPCR, Rhodopsin. Journal of Neuroscience. 33(34). 13621–13638. 51 indexed citations
19.
Jerić, Ivanka, et al.. (2011). Development and validation of a liquid chromatography–tandem mass spectrometry method for the quantification of opiorphin in human saliva. Journal of Chromatography B. 879(32). 3920–3926. 14 indexed citations
20.
Nemet, Ina, Christopher Strauch, & Vincent M. Monnier. (2010). Favored and disfavored pathways of protein crosslinking by glucose: glucose lysine dimer (GLUCOLD) and crossline versus glucosepane. Amino Acids. 40(1). 167–181. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026